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Purpose: To develop an accelerated motion corrected 3D whole‐heart imaging  
approach (qBOOST‐T2) for simultaneous high‐resolution bright‐ and black‐blood 
cardiac MR imaging and quantitative myocardial T2 characterization.
Methods: Three undersampled interleaved balanced steady‐state free precession  
cardiac MR volumes were acquired with a variable density Cartesian trajectory and dif-
ferent magnetization preparations: (1) T2‐prepared inversion recovery (T2prep‐IR),  
(2) T2‐preparation, and (3) no preparation. Image navigators were acquired prior the 
acquisition to correct for 2D translational respiratory motion. Each 3D volume was 
reconstructed with a low‐rank patch‐based reconstruction. The T2prep‐IR volume 
provides bright‐blood anatomy visualization, the black‐blood volume is obtained 
by means of phase sensitive reconstruction between first and third datasets, and T2 
maps are generated by matching the signal evolution to a simulated dictionary. The 
proposed sequence has been evaluated in simulations, phantom experiments, 11 
healthy subjects and compared with 3D bright‐blood cardiac MR and standard 2D 
breath‐hold balanced steady‐state free precession T2 mapping. The feasibility of the 
proposed approach was tested on 4 patients with suspected cardiovascular disease.
Results: High linear correlation (y = 1.09 × −0.83, R2 = 0.99) was found between 
the proposed qBOOST‐T2 and T2 spin echo measurements in phantom experi-
ment. Good image quality was observed in vivo with the proposed 4x undersampled 
qBOOST‐T2. Mean T2 values of 53.1 ± 2.1 ms and 55.8 ± 2.7 ms were measured 
in vivo for 2D balanced steady‐state free precession T2 mapping and qBOOST‐T2, 
respectively, with linear correlation of y = 1.02x+1.46 (R2 = 0.61) and T2 bias = 
2.7 ms.
Conclusion: The proposed qBOOST‐T2 sequence allows the acquisition of 3D high‐
resolution co‐registered bright‐ and black‐blood volumes and T2 maps in a single 
scan of ~11 min, showing promising results in terms of T2 quantification.
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1 |  INTRODUCTION
Cardiac MR (CMR) is a powerful tool for the assessment 
of a wide range of pathologies such as congenital heart dis-
ease, coronary artery disease, myocardial inflammation and 
edema.1-3 However, several CMR sequences with different 
acquisition planning and geometries are needed to assess 
these pathologies. In particular, bright‐blood imaging can 
be used to visualize whole‐heart anatomy and the great tho-
racic vessels.4 Black‐blood imaging provides visualization 
of atrial/ventricular myocardial, aortic and pulmonary wall 
and enables thrombus/hemorrhage detection.5 T2 mapping 
enables noncontrast quantitative tissue characterization, with 
increased myocardial T2 values reported to correlate with 
edema that can be associated with acute myocardial infarc-
tion,6,7 cardiomyopathies8,9 and transplant rejection.10
Bright‐blood CMR angiography (CMRA) for coronary 
and whole heart anatomy visualization is conventionally 
performed free‐breathing with 1D diaphragmatic naviga-
tor (dNAV) gating.11 Similarly, thrombus/hemorrhage vi-
sualization is typically performed with a 3D free‐breathing 
noncontrast enhanced black‐blood T1‐weighted inversion 
recovery (IR) technique5 with 1D dNAV. 1D navigator gat-
ing approaches minimize respiratory motion by acquiring 
data only when the navigator signal is within a small gat-
ing window (~5‐6 mm), leading to long and unpredictable 
scan times. To enable shorter and more predictable scan 
times several self‐gating techniques have been proposed to 
directly track and correct for the respiratory motion of the 
heart.12-18 Conventional cardiac T2 maps are acquired with 
T2 prepared balanced steady‐state free precession (bSSFP) 
in 2D short‐axis views, under several breath‐holds, requir-
ing patient cooperation and expert planning. T2 preparation 
(T2prep) pulses with increasing T2prep durations are used 
to acquire several T2‐weighted images that follow an expo-
nential T2 decay curve.19-21 A pause time of several cardiac 
cycles is used to allow for T1 recovery before applying the 
next T2 prepared imaging series.3 Typically, only a single 2D 
slice can be acquired for each breath hold leading to limited 
spatial resolution and coverage. High‐resolution free breath-
ing 3D T2 mapping of the heart has been demonstrated using 
1D dNAV but leads to long and unpredictable scan times,20 
hindering the acquisition of high isotropic resolution images. 
1D dNAVs have also been used to correct for foot‐head trans-
lational respiratory motion with ~100% scan efficiency,21 en-
abling shorter scan times; however, the heart is not directly 
tracked with this approach and a motion model to relate the 
diaphragmatic to cardiac motion is needed. 1D respiratory 
self‐navigation has been investigated for 3D radial trajecto-
ries, enabling the acquisition of 1.7 mm isotropic T2 maps 
in ~18 min.22 However, acquisition time (TA) remains a chal-
lenge with this approach because a heart beat is necessary 
between acquisitions to allow magnetization recovery.
Furthermore, the sequences (bright‐blood, black‐blood, 
and T2 mapping) are usually performed sequentially, with 
different geometries (2D and 3D) and orientations, and 
under different breathing conditions (i.e., breath‐hold and 
free‐breathing), leading to prolonged TAs and potential miss‐ 
registration errors between the images. To partially overcome 
this problem, a T2 prepared Bright‐blood and black‐blOOd 
phase SensiTive (BOOST) IR sequence23 has been recently 
proposed to provide respiratory motion compensated and 
co‐registered bright‐ and black‐blood 3D whole‐heart images. 
Nevertheless, this sequence is unable to provide quantita-
tive tissue characterization and still requires long scan times 
(~20 min with fully sampled acquisitions).
The aim of this work was to develop a novel acceler-
ated and respiratory motion compensated 3D whole‐heart 
sequence (qBOOST‐T2), which provides co‐registered high‐
resolution 3D bright‐blood, black‐blood, and quantitative T2 
map volumes from a single free‐breathing scan of ~11 min. 
This was achieved by extending the BOOST sequence23 
to enable undersampled acquisition and to provide high‐ 
resolution 3D whole‐heart T2 maps. The proposed sequence 
is based on the acquisition of 3 interleaved datasets with dif-
ferent magnetization preparation pulses. The first volume 
provides bright‐blood anatomy visualization, the black‐blood 
volume is obtained by means of phase sensitive IR (PSIR), ‐like 
reconstruction24 between the first and third datasets, and 
T2 maps are generated by matching the signal evolution to a 
simulated dictionary.
2 |  METHODS
2.1 | qBOOST‐T2 framework
The proposed 3D whole‐heart electrocardiograph triggered 
qBOOST‐T2 mapping sequence is shown in Figure 1. Three 
interleaved bright‐blood bSSFP volumes were acquired with 
an undersampled variable density Cartesian trajectory with 
spiral‐like profile order.24,25 A nonselective T2prep‐IR mod-
ule with T2prep length = 50 ms and TI = 110 ms was applied 
before the first dataset acquisition. T2 preparation (T2prep 
length = 30 ms) was performed before the second volume, 
K E Y W O R D S
3D whole‐heart, black‐blood imaging, bright‐blood cardiac anatomy, respiratory motion correction,  
T2 mapping
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whereas the third dataset is acquired with no preparation. 
Fat suppression was achieved with a short inversion time IR 
(STIR) approach26 in the first dataset, whereas spectral pre-
saturation fat suppression (SPIR, spectral presaturation IR)27 
was used in the second and third datasets.
2D low‐resolution iNAVs were acquired before the acqui-
sition of each volume to estimate and correct for superior‐ 
inferior (SI) and left‐right (LR) translational respiratory 
motion, enabling 100% respiratory scan efficiency. A template‐ 
matching algorithm with a mutual information similarity 
measure28 was used to estimate SI and LR beat‐to‐beat trans-
lational motion from the iNAVs. Outliers due to deep breaths 
(outside the interval calculated as mean ± 2 standard devia-
tions) were removed and 2D translational motion correction 
is performed as a linear phase shift in k‐space.29
Each undersampled translational motion corrected 3D 
volume was independently reconstructed with a 3D low‐rank 
patch‐based reconstruction (3D‐PROST).25 PROST undersam-
pled reconstruction exploits local (within a patch) and nonlocal 
(between similar patches within a neighborhood) redundan-
cies of the 3D volumes in an efficient low‐rank formulation. 
The reconstruction is formulated as an iterative 2‐step process: 
(1) a L2‐norm regularized parallel image reconstruction using 
the denoised volume from step 2 as prior knowledge, and 
(2) a low‐rank patch based denoising. The first step is solved 
using conjugate gradient whereas the second step is solved by 
using a truncated singular value decomposition.
3D affine image registration was performed between the 
3 reconstructed volumes. The T2prep‐IR volume provided 
bright‐blood anatomy visualization, while a PSIR‐like recon-
struction24 between the first and third acquired volume was 
performed to obtain the black‐blood dataset. Whole‐heart 
T2 maps were generated by matching the measured signal 
evolution of each voxel through the 3 motion corrected and 
reconstructed volumes to the closest entry of a subject‐ 
specific dictionary obtained by means of extended phase 
graphs (EPG) simulations.25 EPG simulations provide the 
evolution of transversal and longitudinal magnetization for 
the given sequence and avoid the use of recovery periods, 
usually needed for the complete recovery of the longitudinal 
magnetization. The dictionary generation and the matching 
step between measured and simulated signal are described in 
more detail hereafter.
2.2 | Dictionary generation and matching
EPG simulations were carried out to generate a subject‐
specific dictionary. Trigger delay and acquisition window 
F I G U R E  1  Framework of the proposed 3D whole‐heart qBOOST‐T2. Acquisition (A), Three undersampled interleaved bSSFP bright‐blood 
volumes are acquired with: (1) T2prep‐IR, (2) T2prep, and (3) no preparation modules, respectively. 2D‐iNAVs are acquired in each heartbeat 
before image acquisition. Reconstruction (B), image navigators are used to estimate/correct SI and LR translational motion. Translational beat‐
to‐beat motion correction is performed on the 3 datasets independently and each volume is reconstructed with 3D PROST reconstruction. PSIR 
reconstruction (C), Black‐blood images are obtained by performing a PSIR reconstruction between the dataset acquired with T2prep‐IR preparation 
(bright‐blood image) and the third volume as a phase reference. T2 map generation (D), T2 map is generated by matching the measured signal and 
a previously generated EPG simulated dictionary. The first dataset acquisition includes a STIR fat suppression (TI = 110 ms), whereas the second 
and third datasets use a SPIR pulse for fat saturation
1676 |   MILOTTA eT AL.
parameters were specified for each simulation according to 
the heart rate (HR) and mid‐diastolic resting period of the 
subject. Taking into account the centric k‐space reordering 
of the acquisition trajectory, the simulated dictionary was 
generated considering the mean absolute value of the sig-
nal for the k‐space central region (40% of the readouts per 
heartbeat), containing contrast information. Longitudinal 
magnetization evolution was used to determine the signal 
magnetization polarity. The dictionary was generated with 
3 different T1 values = (900, 1100, 1300) ms and variable 
T2 values in the range (minimum: step size: maximum) 
(4:2:100,105:5:200,210:10:450) ms.30 Healthy myocardium 
value at 1.5T is T1 = 1100 ms31; however, additional T1s 
(900 ms and 1300 ms) were included in the dictionary to ac-
count for possible sources of T1 variability. The simulated 
T2 value range was selected to enable coverage of a wide 
range of T2s, including healthy myocardium (T2 ~ 50 ms), 
diseased myocardium (i.e., edema T2 ~ 60 ms), and blood 
(T2 ~ 250 ms).3 Quantitative T2 maps were generated by 
matching each measured and normalized signal evolution 
to a specific dictionary entry, corresponding to a unique T2 
value. The matching was performed minimizing the least 
square error between the measured signal and the EPG‐based 
dictionary entry.
Before matching, 2 PSIR reconstructions were performed 
between the T2prep‐IR prepared and the nonprepared data-
sets and between T2‐prepared and nonprepared datasets. 
These PSIR reconstructions were used to systemically restore 
signal polarity that would affect the matching with the sim-
ulated dictionary. The 3 translational motion corrected vol-
umes were normalized in time by dividing each voxel in each 
volume by the root mean square of the corresponding voxels 
in the 3 volumes. The obtained datasets were used to obtain 
the normalized signal evolution, through the 3 acquired vol-
umes, for each voxel.
2.3 | Experimental design
The proposed qBOOST‐T2 sequence was tested in simu-
lations, in a T2 phantom, on 11 healthy subjects (5 males; 
mean age, 29 years; range, 27‐35 years) and on 4 patients 
with suspected cardiovascular disease (3 males; mean age, 
51 years; range, 25‐75 years). Acquisition was performed on a 
1.5T MR scanner (MAGNETOM Aera, Siemens Healthcare, 
Erlangen, Germany) with an 18‐channel chest coil and a 
32‐channel spine coil. Written informed consent was obtained 
from all participants before undergoing the MR scans and the 
study was approved by the Institutional Review Board.
2.3.1 | Simulations
EPG simulations were carried out to investigate the 
matching sensitivity to long T1 and T2 pairs and the T2 
dependency on different simulated HRs. Signal evolution 
for different T1 and T2 pairs, ranging, respectively, be-
tween T1 = (800:100:1400) ms and T2 = (40:6:88) ms 
were simulated and matched to an EPG dictionary gener-
ated with T1 = (900, 1100, 1300) ms and T2 = (4:2:50, 
50:5:200, 200:10:450) ms. HR dependency was assessed 
by matching the signal evolution generated with different 
T2 = (40:6:88) ms, fixed T1 = 1100 ms and variable HR = 
(40:20:120) beats per min (bpm) to a dictionary with 
T1 = (900, 1100, 1300) ms and T2 = (4:2:50, 50:5:200, 
200:10:450) ms.
2.3.2 | Phantom
Data acquisition was performed in an in‐house developed 
T2 phantom to test the sequence ability to differentiate 
between healthy and diseased myocardium (T2myoc = 52 
ms and T2myoc‐diseased = 65 ms). The phantom consists of 6 
vials with increasing agar concentrations (0.8, 1, 1.5, 2, 3, 
and 5%).32 Spin echo (SE) and IR spin echo (IRSE) experi-
ments were performed to characterize, respectively, the T2 
and T1 of the phantom. The SE acquisition parameters in-
cluded transversal orientation, field of view (FOV) = 280 × 
280 × 20 mm3, resolution= 2 × 2 × 4 mm3, TR = 10 s, 
TEs = (15, 30, 60, 120, 240, 480) ms and total TA of 2 h 
and 12 min. The IRSE was acquired with TR = 10 s, TE = 
12 ms and TIs = (50, 100, 150, 300, 500, 1000, 2000, 3000) 
ms in a total TA = 6 h and 16 min. Reference T2 and T1 
values obtained with the SE and IRSE experiments are 
shown in Supporting Information Table S1, which is avail-
able online.
Acquisition parameters for qBOOST‐T2 included: 
bSSFP acquisition with centric k‐space ordering, transver-
sal orientation, resolution = 1 × 1 × 2 mm3, FOV = 280 × 
280 × 20 mm3, TI = 110 ms, T2prep1st‐volume = 50 ms, 
T2prep2nd‐volume = 30 ms, flip angle (FA) = 90 degrees, 
simulated HR = 60 bpm, trigger delay = 700 ms, TE/TR = 
1.57/3.6 ms, bandwidth = 822 Hz/pixel, 14 start‐up echoes 
for iNAVs acquisition, 30 segments per heart beat corre-
sponding to an acquisition window of 110 ms, and acceler-
ation factor of 4 for each volume leading to a total scan time 
~3 min. The conventional T2 prepared 2D T2 map was ac-
quired with a bSSFP sequence with FA = 70 degrees, FOV = 
290 × 360 mm2, resolution = 1.8 × 1.8 mm2, slice thick-
ness = 8 mm, TE/TR = 1.18/3.5 ms, bandwidth = 1185 
Hz/pixel, simulated heartbeat = 60 bpm, trigger delay = 
700 ms, T2prep preparations = (0, 28, 55) ms, 3 recovery 
heart beats and linear k‐space ordering.3 Three slices were 
acquired in transversal direction with acquisition time of 
12 heart beats per slice. Additionally, phantom acquisitions 
were performed with different HRs = (40:20:120) bpm to 
investigate the HR dependency on T2 quantification using 
qBOOST‐T2.
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2.3.3 | Healthy subjects
Data were acquired with the proposed qBOOST‐T2, conven-
tional 2D bSSFP T2 mapping, and 3D CMRA sequence with 
iNAV‐based respiratory motion correction14 for comparison 
purposes. Imaging parameters for qBOOST‐T2 included: 
coronal orientation, resolution= 1 × 1 × 2 mm3, FOV = 320 × 
320 × 96‐104 mm3, TI = 110 ms, T2prep1st‐volume = 50 ms, 
T2prep2nd‐volume = 30 ms, FA = 90 degrees, TE/TR = 
1.57/3.6 ms, bandwidth = 822 Hz/pixel, 14 start‐up echoes 
for iNAVs acquisition, and acceleration factor of 4 for each 
volume leading to a total scan time 11 ± 1.2 min. The 3D 
CMRA dataset was acquired with a fully sampled bSSFP se-
quence and imaging parameters matching the qBOOST‐T2 
acquisition with a single T2prep of 40 ms, resulting in a total 
scan time 11.5 ± 1.4 min. Imaging parameters for the stand-
ard 2D T2 mapping were set as follows: resolution = 1.8 × 
1.8 mm2, slice thickness = 8 mm, FOV = 290 × 360 mm2, 
FA = 70 degrees, TE/TR = 1.18/3.5 ms, bandwidth = 1185 
Hz/pixel, T2prep preparations = (0, 28, 55) ms with 3 heart 
beats for magnetization recovery, 3 short axis slices (base, 
mid, apex) were acquired in a 10 heart‐beats breath‐hold per 
slice. All acquisitions were electrocardiograph triggered and 
performed during mid‐diastolic resting period. Trigger delay 
ranged between 548 and 950 ms and acquisition window 
ranged between 85 and 125 ms corresponding to 24‐34 seg-
ments acquired per heartbeat. The acquisition parameters of 
the different used sequences are summarized in Supporting 
Information Table S2.
2.3.4 | Patients
The feasibility of the proposed qBOOST‐T2 sequence was 
tested on 4 patients with suspected cardiovascular disease. 
Imaging acquisition parameters matched the healthy subject 
scans. The patients were, respectively, 25, 75, 41, and 63 
years old with an average HRs of 45, 72, 85, and 76 bpm. A 
conventional 2D bSSFP T2 prepared mapping sequence was 
acquired for comparison purposes with the same imaging pa-
rameters used for the healthy subject study.
2.4 | Reconstruction
2D T2 maps were reconstructed in‐line using the scanner 
software (Syngo MR E11A, Siemens Healthcare, Erlangen, 
Germany). Nonrigid motion correction to compensate for in‐
plane motion between 2D T2 weighted images and exponen-
tial pixel‐wise fitting were performed in‐line on the scanner.
qBOOST‐T2 and CMRA raw data were exported from the 
scanner and reconstructed in MATLAB (The MathWorks, 
Inc., Natick, MA) on a dedicated workstation (16‐core Dual 
Intel Xeon Processor, 2.3 GHz, 256 GB RAM). Translational 
motion correction to end‐expiration was performed 
individually on each qBOOST‐T2 dataset in vivo. The 3 
datasets were independently reconstructed using 3D‐PROST, 
with reconstruction parameters set as suggested in Bustin 
et al.25 Total reconstruction time for each of the 3 datasets 
was 18 min. The T2prep‐IR dataset enables bright‐blood 
anatomical visualization, whereas the black‐blood volume 
was obtained after PSIR reconstruction between the first and 
third datasets. Finally, the 3 acquired datasets were normal-
ized, and dictionary matching was performed to obtain the 
T2 map, as previously described. The averaged time to gener-
ate the dictionary was 2 min and 28 s, whereas the averaged 
matching time for the entire 3D T2 map was 32.4 s, using a 
classical least square error minimization.
The 2D translational motion correction to end‐expiration 
was performed on the fully sampled CMRA dataset and a 
sensitivity‐weighted coil combination was performed.33
2.5 | Data analysis
2.5.1 | Phantom
Conventional 2D bSSFP T2 map and 3D qBOOS‐T2 were 
compared in terms of accuracy with respect to the SE ref-
erence. T2 dependency of dictionary T1 was evaluated by 
matching the measured signal to 3 different dictionaries: T1s 
1st dictionary = (900, 1100, 1300) ms, T1s 2nd dictionary = 
(900, 1100, 1300, 1600, 1800) ms, and T1s 3rd dictionary = 
(900, 1100, 1300, 1600, 1800, 2000, 2400, 2600) ms. HR de-
pendency was assessed by performing different acquisitions 
with HR = (40:20:120) bpm.
2.5.2 | Healthy subjects
Quantitative analysis was performed for the 3D T2 maps 
generated with qBOOST‐T2 and the conventional 2D T2 
mapping sequence. 3D T2 maps from qBOOST‐T2 were 
reformatted to the same slice position as the correspond-
ing 2D T2 maps. Mean T2 values were measured for both 
sequences by selecting a region of interest (ROI) in the 
myocardial septum. The standard deviation of the T2 meas-
urements within the ROI was used to quantify the precision 
of the techniques. Additionally, a Bland Altman analysis was 
performed to evaluate the agreement between the proposed 
qBOOST‐T2 mapping technique and the conventional 2D T2 
mapping approach.
The American Heart Association 17‐segment model34 was 
used to evaluate the percentage of variation of mean T2 and 
T2 precision between 2D bSSFP and 3D qBOOST‐T2. The 
myocardial T2 values of the whole ventricle were measured 
in 16 American Heart Association segments in 3 slice posi-
tions: basal, mid and apex. The 17th segment was excluded 
from the analysis as the coverage of the reference 2D T2 map 
was not sufficient to visualize the apical cap. The percentage 
1678 |   MILOTTA eT AL.
errors of variation were calculated for each segment and each 
subject as:
The percentage errors of variation were averaged across 
subjects and displayed as bull’s eye plots and bar plots. The 
T2 homogeneity in the whole left ventricle was evaluated for 
a representative healthy subject by generating a histogram 
of per‐pixel T2 values and quantifying the T2 distribution 
through different coronal slices.
2.5.3 | Patient
Mean and standard deviation in T2 quantification were eval-
uated and compared with conventional 2D bSSFP T2 map-
ping by selecting a ROI in the septum of the myocardium 
in apical, mid and basal short axis slices. The American 
Heart Association 17‐segment model was used to compare 
the conventional 2D T2 maps and the proposed qBOOST‐T2 
mapping in terms of mean T2 value and precision across the 
whole left ventricle for a representative patient.
3 |  RESULTS
All data acquisitions and reconstructions were carried out 
successfully and results are reported hereafter.
3.1 | Simulations
EPG simulation results are shown in Figure 2. A T2 variabil-
ity < 5% was observed for each simulated T2 value for T1 
ranging between 800 and 1400 ms (Supporting Information 
Figure S1). No T2 variation was observed as function of dif-
ferent HRs.
3.2 | Phantom
The quantified T2 values obtained with reference SE, 2D 
bSSFP T2 map, and 3D qBOOST‐T2 are shown in Figure 3A. 
A T2 overestimation is observed with the conventional 2D 
T2 mapping sequence, especially for high T2 values, al-
though high linear correlation was observed (y = 1.25x + 
2.44 with R2 = 0.99). A better agreement in T2 quantification 
was found between qBOOST‐T2 and SE with linear correla-
tion y = 1.09x – 1.67 (R2 = 0.99); however, overestimation 
of long T2 values was observed.
T2 dependency on the T1 dictionary used is shown in 
Figure 3B. Including additional T1 values improves the 
dictionary matching accuracy for longer T2 values (corre-
sponding also to longer T1 values) and reduces the standard 
deviation within a phantom vial. A variation of 3.2% and 
3.8% was observed, respectively, for T2 values that corre-
spond to healthy myocardium T2myoc = 52 ms and diseased 
myocardium T2myoc‐diseased = 65 ms, whereas a variation 
of 8.6% was observed for a long T2 = 115 ms. However, 
T1s > 1400 ms are not expected in vivo; therefore, these 
values were not included in the dictionary used to match T2 
values in healthy subject and patient acquisitions to reduce 
computational time.
The results of the experiments to investigate HR depen-
dency are shown in Figure 3C. A variation in T2 quanti-
fication between 8.2% and 11.6% was observed for all the 
phantom vials. Additionally, T2 matched standard deviation 
increased at high HR (100 and 120 bpm), particularly for 
long T2 values.
T2Mean_variation=
(
T2Mean_qBOOST −T2Mean_bSSFP
)
∕T2Mean_bSSFP×100
T2Std_variation=
(
T2Std_qBOOST −T2Std_bSSFP
)
∕T2Std_bSSFP×100
F I G U R E  2  EPG simulations performed to investigate T1 and different HR dependency of the proposed technique. A, Signal evolution 
of T1/T2 pairs with T2 = (40:6:88) ms and T1 = (800:100:1400) ms were matched to a EPG dictionary with T1 = (900, 1100, 1300) ms. A T2 
variability < 5% was observed for all the different T2 values. B, T2 values matched for different simulated HRs. The matched T2 is insensitive to 
HR variability in simulations experiments
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3.3 | Healthy subjects
Coronal, transversal, short axis, and 4‐chamber views of 2 
representative healthy subjects acquired with the proposed 
qBOOST‐T2 are shown in Figure 4. Bright‐blood, black‐
blood volumes, and T2 maps are shown, respectively, in 
first, second, and third columns. Atria, ventricles, aorta, and 
papillary muscles are visible in the anatomical bright‐ and 
black‐blood images for both subjects. Good left ventricle 
delineation is observed in the T2 maps of both subjects. 
Additionally, 3 Supporting Information Videos S1, S2, and 
S3 show the bright‐blood, black‐blood 3D volumes, and the 
co‐registered 3D T2 map for 1 representative healthy subject.
Short axis reformatted anatomical bright‐ and black‐
blood images and T2 map are shown for a different healthy 
subject in Figure 5A. The 3D nature of the acquisition 
allows whole coverage from the apex to the base of the 
myocardium. Bull’s eye plot of mean myocardium T2 quan-
tification and T2 standard deviation are shown in Figure 5B, 
uniform T2 values are observed across the different 
segments, although lower precision (corresponding to a 
higher standard deviation) is observed in the inferior part of 
the left ventricle. A histogram of per‐pixel T2 distribution 
is shown in Figure 5C. The mean and standard deviation 
of T2 distribution were 49.1 ms and 4.8 ms, respectively, 
whereas maximum and minimum matched T2 values were 
71 and 22 ms. Additionally, T2 distribution through coro-
nal slices showed a linear correlation of y = 0.02x + 48.38 
(Figure 5D).
Coronal, 4‐chamber views and coronary reformatted im-
ages obtained with bright‐blood qBOOST‐T2 and CMRA are 
shown in Figure 6 for a representative healthy subject. Both 
approaches show clear delineation of aortic wall, papillary 
muscles, and coronary arteries.
T2 maps generated with the proposed approach were 
compared with conventional 2D bSSFP T2 mapping quali-
tatively and in terms of T2 quantification. The 2D short axis 
views and the reformatted short axis views obtained with 
qBOOST‐T2 are shown in Figure 7 for 10 healthy subjects.
F I G U R E  3  Phantom experiments. A, T2 quantification obtained with reference SE experiment, 2D standard bSSFP T2 mapping and the 
proposed qBOOST‐T2 sequence for 6 vials with different agar concentration. B, T2 dependency of the proposed sequence to different T1 values 
included in the dictionary. 1st T1 dictionary = (900, 1100, 1300) ms, 2nd T1 dictionary = (900, 1100, 1300, 1600, 1800) ms, and 3rd T1 dictionary =  
(900, 1100, 1300, 1600, 1800, 2000, 2400, 2600) ms. A variation of 3.2% and 3.8% is observed, respectively, for T2 values that corresponds to 
healthy myocardium T2myoc = 55 ms and diseased myocardium T2myoc‐diseased = 65 ms, whereas a variation of 8.6% was observed for a long 
T2 = 115 ms. C, T2 dependency to different simulated HRs. A T2 variation between 8.2% and 11.6% for HR ranging between 40 and 120 bpm was 
observed for all the phantom vials
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Quantitative analysis was carried out for all healthy sub-
jects. Mean T2 value and standard deviation measurements 
in a septal ROI are shown in Figure 8. Good agreement 
with linear correlation y = 1.02x + 1.46 (R2 = 0.61) was 
found between the conventional 2D bSSFP T2 mapping 
and qBOOST‐T2. The average T2 values obtained with 2D 
bSSFP and 3D qBOOST‐T2 sequences were T2 = 53 ± 2 ms 
and T2 = 55 ± 3 ms, respectively. A statistically significant 
(P = 0.0003) slight overestimation in T2 quantification was 
observed with the proposed method. The proposed approach 
F I G U R E  4  Two representative healthy subjects acquired with the proposed qBOOST‐T2 sequence. 3D high‐resolution bright‐blood  
(first column), black‐blood (second column), and T2 maps (third column) are co‐registered. Coronal, short axis, transversal, and 4‐chamber views 
are shown. Acquisition parameters included: 3D bSSFP, T2prep1st‐heartbeat = 50 ms, T2prep2nd‐heartbeat = 30 ms, TI = 110 ms, FA = 90 degrees, 
resolution = 1 × 1 × 2 mm, 4× undersampling, 14 start‐up echoes for iNAV acquisition
F I G U R E  5  A, Bright‐blood, black‐blood, and T2 map short‐axis views from apex to base are shown for 1 representative healthy subject. 
The 3D nature of the acquisition permits to obtain complete coverage of the heart. B, Bull’s eye plot of average T2 quantification and T2 standard 
deviation show uniform T2 quantification in all the different segments. C, Histogram of per‐pixel T2 distribution through the whole left ventricle. 
D, Averaged T2 distribution through coronal slice. Uniform T2 quantification is observed in the left ventricle
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F I G U R E  6  Comparison between 
bright‐blood anatomical images (first 
column), black‐blood images (second 
column) acquired with qBOOST‐T2 (A), 
and bright‐blood CMRA (B) for 1 healthy 
subject. Coronal, 4‐chamber views, and 
coronary artery reformats are shown in first, 
second, and third row, respectively
F I G U R E  7  Comparison between 2D short‐axis standard T2 maps and short‐axis reformatted 3D qBOOST‐T2 maps for 10 healthy subjects. 
qBOOST‐T2 maps have been reformatted to the same slice position of the acquired 2D bSSFP T2 maps. Comparable visual image quality is 
obtained with the 2 approaches
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showed a slightly lower precision with respect to the standard 
2D T2 mapping technique (4.09 ± 1.25 ms and 5.19 ± 10.9 
ms for standard T2 mapping and qBOOST‐T2, respectively); 
however, it was not statistically significant. T2 quantification 
obtained with standard 2D bSSFP T2 mapping and qBOOST‐
T2 mapping were also compared in a Bland‐Altman analysis 
(Figure 8C). A mean difference of 2.71 ms was observed be-
tween the 2 mapping techniques and the limits of 95% agree-
ment were 0.61 ms and 6.03 ms.
Bar and bull’s eye plots of the percentage of variation 
of mean T2 value and T2 standard deviation are shown in 
Figure 9. An overestimation of T2 is obtained with qBOOST‐
T2 approach with respect to conventional 2D bSSFP in all 
left ventricular segments. Additionally, a lower precision is 
observed, especially in the inferior part of the left ventricle. 
However, precision may be affected not only by the different 
sequences but also by different imaging parameters, such as 
slice thickness and resolution. The effect of averaging con-
tiguous 3D qBOOST‐T2 slices on precision has been inves-
tigated and the results are shown in Supporting Information 
Figure S2. Similar findings were obtained by investigating the 
effect of image resolution on T2 quantification (Supporting 
Information Figure S3).
3.4 | Patients
The average scan time for the proposed qBOOST‐T2 was 
10 min and 35 s. Bright‐ and black‐blood images, and T2 
F I G U R E  8  Quantification of septal myocardium mean T2 and precision of the proposed qBOOST‐T2 technique and comparison with 
conventional 2D T2 mapping. A, Comparison between myocardial mean T2 obtained with conventional 2D T2 mapping (gray) and the proposed 
3D qBOOST‐T2 mapping sequence (blue) for each healthy subject. Good agreement is observed in terms of mean T2 between the 2 approaches.  
B, Comparison between myocardial T2 precision (measured as standard deviation with in a septal ROI) obtained with conventional 2D T2 mapping 
(gray) and the proposed 3D qBOOST‐T2 mapping sequence (blue) for each healthy subject. C, Bland Altman plot comparing the proposed 
qBOOST‐T2 sequence with the conventional 2D bSSFP T2 mapping technique. Good agreement is observed between the 2 approaches. A slight 
T2 overestimation is obtained with qBOOST‐T2mapping (bias = 2.71 ms), however, T2 quantification is within the 95% interval. D, Comparison 
between precision obtained with standard T2 mapping and the proposed qBOOST‐T2. A slightly lower (not significant) precision is observed with 
the proposed qBOOST‐T2 sequence. Myocardial T2 accuracy and precision were measured in a ROI in the septum of the myocardium
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maps reformatted in coronal orientations are shown in 
Figure 10. Corresponding conventional 2D bSSFP T2 maps 
are also included in Figure 10 for comparison purposes. 
Myocardial septal T2 values were measured in apical, mid 
and basal slices for each subject and the results are reported 
in Supporting Information Table S3. A general overestima-
tion (bias of 2.3 ms) and lower precision with respect to 
conventional 2D bSSFP T2 mapping was observed with the 
proposed approach. Bull’s eye plot of mean myocardium 
T2 quantification and T2 standard deviation are shown in 
Supporting Information Figure S4A for a representative pa-
tient. A histogram of per‐pixel T2 distribution is shown in 
Supporting Information Figure S4B. The mean and standard 
deviation of T2 distribution were 46.5 ms and 6.8 ms, respec-
tively. T2 distribution through coronal slices showed a linear 
correlation of y = −0.03x + 47.3 (Supporting Information 
Figure S4C).
4 |  DISCUSSION
In this study, a 3D free‐breathing accelerated qBOOST‐T2 
sequence for simultaneous and co‐registered acquisition of 
anatomical high‐resolution bright‐blood and black‐blood 
volumes and a 3D T2 map has been proposed.
This approach was based on the acquisition of three 4× 
undersampled interleaved bright‐blood whole‐heart data-
sets acquired with different magnetization preparations: (1) 
T2prep‐IR preparation module, (2) T2 preparation, and (3) 
no preparation. The T2prep‐IR prepared dataset provided 
bright‐blood anatomical visualization, the black‐blood vol-
ume was obtained by performing a PSIR reconstruction 
between the first and third dataset and the 3D T2 map was 
generated by matching the acquired signal evolution to a dic-
tionary obtained by means of EPG simulations. The use of 
2D image‐based navigators allowed SI and LR translational 
F I G U R E  9  Percentage of variation of mean T2 (A) and T2 precision (B) between 2D bSSFP and 3D qBOOST‐T2. T2 overestimation  
and a lower precision are observed in each segment of the left ventricle. A, anterior; S, septal; I, inferior; L, lateral; AS, anterior‐septal; IS,  
inferior‐septal; IL, inferior‐lateral; AL, anterior‐lateral
1684 |   MILOTTA eT AL.
motion correction with 100% respiratory scan efficiency and 
predictable scan time. Whereas, the use of a 3D patch‐based 
PROST reconstruction enabled 4× undersampled acquisition 
preserving good visual image quality.
The proposed qBOOST‐T2 has been designed to enable a 
comprehensive assessment of the heart including anatomical 
visualization and T2 myocardial tissue quantification in a sin-
gle free‐breathing scan, thus overcoming some of the limita-
tions of current sequential acquisitions, such as misalignment 
and long scan times. The 3D acquisition allowed whole‐heart 
myocardium coverage in comparison to conventional breath‐
hold 2D T2 mapping maintaining uniform T2 quantification 
across the whole left ventricle and across different slices. 
Additionally, the nearly isotropic high‐resolution nature 
of the acquisition permitted to reformat the co‐registered 
bright‐blood, black‐blood volumes, and T2 maps in different 
orientations (coronal, transversal, short‐axis, and 4‐chamber) 
preserving good image quality and uniform T2 quantification 
in a clinically feasible scan time, in comparison to recently 
proposed 3D T2 mapping methods with lower resolution that 
do not allow reformatting the 3D volume in different orienta-
tions35,36 or that requires long acquisition time.37
The proposed qBOOST‐T2 approach showed good accu-
racy and precision with respect to spin echo reference val-
ues (high linear correlation) in the phantom experiment. T2 
quantification was found to be robust to T1 variability in both 
simulations and phantom experiments (T2 variability <5%). 
Sequence simulations showed robustness to different HRs 
(percentage of variation <5%). Higher dependency on HR 
was observed in the phantom scan (variability of 10%); how-
ever, capability to differentiate between different T2 values 
ranging between 25 ms and 115 ms was observed.
Good delineation of anatomical structures was observed 
in the bright‐blood volume acquired with qBOOST‐T2 
approach. However, lower sharpness was observed in the 
reformatted coronary qBOOST‐T2 image (Figure 6), which 
may be caused by the undersampled nature of the acquisition 
and by residual motion that could affect fine resolution details.
Good agreement in terms of T2 quantification was 
observed between T2 maps obtained with the proposed 
qBOOST‐T2 sequence and standard bSSFP T2 mapping in 
healthy subjects. A slight T2 overestimation and a lower pre-
cision was observed with the proposed approach in compar-
ison to conventional 2D bSSFP T2 mapping. However, the 
difference in measured precision was not statistically signifi-
cant. The bias in T2 quantification between qBOOST‐T2 and 
2D bSSFP T2 mapping calculated with the Bland‐Altman 
analysis was 2.7 ms (within the limits of 95%). The slight T2 
overestimation of qBOOST‐T2 with respect to 2D bSSFP T2 
mapping was likely due to the different k‐space ordering used 
by both sequences (centric for qBOOST‐T2 and linear for 
conventional 2D T2 mapping), as has been reported before.3 
Whereas, the high‐resolution 3D nature of qBOOST‐T2 (slice 
thickness = 2 mm) may explain the lower precision observed 
F I G U R E  1 0  Comparison between 2D short‐axis standard T2 maps and short‐axis reformatted 3D qBOOST‐T2 maps for 4 patients with 
suspected cardiovascular disease. Apical, mid, and basal slices are shown for the acquired patients. Additionally, bright‐blood and black‐blood 
short axis reformatted images are shown for the qBOOST‐T2 acquisition. No pathologies were diagnosed for any of the acquired patients
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with the proposed approach with respect to 2D T2 mapping 
(slice thickness = 8 mm). A trade‐off between image reso-
lution, T2 precision, and partial volume have been observed 
(Supporting Information Figures S2 and S3); thus, the lower 
precision observed in the in vivo experiment may not only 
be due to the proposed technique but due to different image 
parameters adopted in the 3D and 2D scans (i.e., resolution). 
Our experiments showed that decreasing the resolution leads 
to an increased precision, associated to the increased signal 
to noise ratio in each acquired volume and thus an increased 
precision. However, it has been previously shown20 that low‐ 
resolution acquisitions may introduce partial volume arte-
facts that could affect T2 quantification and precision.
A general T2 overestimation across the whole myocar-
dium with respect to conventional 2D bSSFP T2 mapping was 
also observed in the bull’s eye plots. However, T2 quantifica-
tion was uniform across the whole 3D volume. A lower preci-
sion was observed particularly in the inferior part of the heart, 
which may be explained by the presence of residual motion in 
the reconstructed images and lower signal to noise ratio due 
to larger distance to the radiofrequency coils. Additionally, 
the inferior region of the heart is located close to the edge of 
the FOV; thus, imperfect shimming could lead to field inho-
mogeneities that would affect the T2 map. Moreover, a lower 
signal to noise is expected in the qBOOST‐T2 acquisition due 
to lower slice thickness.
Preliminary results in 4 patients showed a similar trend 
as noticed in the healthy subject study. A slight T2 overesti-
mation was observed in each acquired short‐axis slice when 
compared with standard 2D bSSFP T2 mapping, with slightly 
lower precision. However, the 3D whole heart coverage of the 
proposed approach provides the flexibility to reformat the ac-
quired volume in any orientation, which could be beneficial 
for the identification of localized pathologies as shown in van 
Heeswijk et al.37
A potential limitation of the proposed work is fat sup-
pression. Different fat suppression techniques are used on 
each acquired dataset because fat signal evolution differs in 
each volume. In the first dataset, a STIR approach is used to 
achieve fat suppression. The inversion pulse of the T2prep‐
IR module was used to null the fat signal with an TI of 110 
ms. In the second and third dataset, a SPIR approach was 
used and spectral presaturation FAs of 110 degrees and 130 
degrees were used to null fat signal in the second and third 
volume, respectively. Both TI and SPIR FAs were optimized 
for a HR of 60 bpm, however, the HR dependency of fat sup-
pression techniques could lead to residual fat signal in 1 or 
more reconstructed volumes. If a suboptimal fat suppression 
is achieved in 1 or more of the acquired volumes an unpre-
dictable signal will be matched in the T2 map: depending 
on the acquired signal evolution, the T2 corresponding to 
the closest dictionary entry to the measured signal will be 
matched. Moreover, residual fat signal could generate partial 
volume artefacts thus affecting the T2 quantification at the 
myocardium‐fat interface. In the presence of partial volume, 
the mixed signal will be matched to the closest signal evolu-
tion entry in the dictionary; however, it will not reflect the 
proper T2 value of the voxel. The least square error of the 
matching process could be used to assess the accuracy of 
the matching in the presence of partial volume artefacts.
The approximation of the standard deviation of the pro-
posed technique used in this study ignores intrinsic variability 
of underlying T2 because uniform mean T2 values were ex-
pected across healthy subjects. However, this approximation is 
valid only when analyzing normal T2 values and percentages 
of the mean should be considered in future patient studies.
An additional limitation of the proposed technique is the 
approximation of respiratory motion as pure translational 
motion in SI and LR directions. Respiration induces addi-
tional displacements of the heart such as translational mo-
tion in the anterior‐posterior direction, as well as rotation 
and nonrigid deformation.38-40 Future studies will focus on 
the implementation and optimization of nonrigid respiratory 
motion correction within the reconstruction.41
A further limitation is the sensitivity to arrhythmia. In the 
presence of arrhythmia, the measured signal would differ from 
the steady state signal expected in the 3 different interleaved 
acquisitions, generating a T2 overestimation or underestima-
tion in the matched T2 maps. Prospective or retrospective 
arrhythmia rejection could be incorporated in the future to 
overcome this limitation. With a prospective arrhythmia re-
jection approach, 3 interleaved beats will be rejected in the 
presence of 1 arrhythmic heart beat and the entire acquisition 
will be repeated with a stabilized HR; however, this approach 
will lead to longer and unpredictable acquisition time. On the 
other hand, by exploiting retrospective arrhythmia rejection, 
all the datasets will be acquired and the data corrupted by 
arrhythmic heart beats will be excluded from the reconstruc-
tion. However, the reconstructed dataset will be further under-
sampled (an undersampling factor of 4 is used to accelerate 
the acquisition); thus, in the presence of high undersampling, 
the image quality of the reconstructed datasets and, therefore, 
of the matched T2 maps may be compromised. Validation of 
the proposed approach in patients with cardiovascular disease 
and challenging acquisition conditions, i.e., arrhythmic heart 
beat will be investigated in future studies.
5 |  CONCLUSIONS
The proposed accelerated qBOOST‐T2 sequence allows the 
acquisition of 3D co‐registered high‐resolution bright‐ and 
black‐blood volumes and T2 map for comprehensive assess-
ment of cardiovascular disease in a clinically feasible scan 
time of ~11 min. The proposed approach shows promising 
results in terms of accurate T2 quantification when compared 
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with conventional 2D T2 mapping. Future work will include 
further validation in patients with cardiovascular disease.
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SUPPORTING INFORMATION
Additional supporting information may be found online in 
the Supporting Information section at the end of the article.
FIGURE S1 EPG simulations performed to assess the 
matched T2 dependency on the T1 used to generate the simu-
lated signal. A, Signal evolution of T1/T2 pairs with T2 = 
(40:6:88) ms and T1 = (800:100:1400) ms were matched to 
a EPG dictionary with fixed T1 = 1100 ms. High T1 depend-
ency was observed for long T2 values. B, Signal evolution of 
T1/T2 pairs with T2 = (40:6:88) ms and T1 = (800:100:1400) ms 
were matched to a EPG dictionary with T1 = (900, 1100, 
1300) ms. T2 matching percentage error was decreased and a 
T2 variation < 5% was observed for almost all the simulated 
signal. C, Maximum variability errors (T1 = 800 and 1400 ms) 
obtained by matching the simulated signal to a dictionary 
with fixed T1 (top row) and a dictionary with T1 = (900, 
1100, 1300) ms (bottom row)
FIGURE S2 A, Effect of averaging contiguous slice on T2 
quantification and T2 precision. Averaging 6 contiguous 
slices leads to a reduction of standard deviation in a sep-
tal ROI from 5.90 ms to 3.39 ms (percentage of variation 
of 42.5%), whereas no effect on T2 quantification was ob-
served (T2 variability of only 1.1%). B, T2 intensity profile 
drawn across a septal region (indicated by the black line) 
for different number of summed slices. Decreasing reso-
lution in the slice direction leads to an increase of partial 
volume effects between blood and myocardium. Indeed, 
a narrower myocardial delineation is observed for a high 
number of summed slices. Additionally, partial volumes 
effects are visible in lower resolution images as shown by 
the black arrow
FIGURE S3 A, Three 3D qBOOST‐T2 maps were generated 
for 1 representative subject with reconstructed resolutions of 
1 × 1 × 2 mm3, 1.5 × 1.5 × 3 mm3 and 2 × 2 × 4 mm3 and 
compared with 2D bSSFP T2 map. B, Mean T2 and T2 pre-
cision measured in the septum of the myocardium as function 
of different reconstructed resolutions for 3D qBOOST‐T2. A 
reduction in standard deviation is observed, whereas a vari-
ability of only 0.96% in myocardial T2 quantification was 
observed between different resolutions. Table: Mean and 
standard deviation of T2 measured in the septum for different 
reconstructed resolutions
FIGURE S4 A, Bull’s eye plot of averaged myocardial T2 
quantification and precision of the proposed qBOOST‐T2 
mapping sequence for patient 2. B, Histogram of per‐pixel 
T2 distribution through the whole left ventricle. C, Averaged 
T2 distribution through coronal slices showed a linear cor-
relation of y = −0.03x + 47.3. Uniform T2 quantification is 
observed in the left ventricle
TABLE S1 T1 and T2 values obtained from Inversion 
Recovery Spin Echo (IRSE) and Spin Echo (SE) experiments 
on a phantom with 6 vials with different agar concentration 
(0.8, 1, 1.5, 2, 3, 5%). The measured T2 values are within 
a range than includes T2 of physiological and pathological 
myocardium (T2myoc = 52 ms T2myoc‐diaseased = 65 ms) 
TABLE S2 Acquisition parameters used in phantom and 
in vivo acquisition for 2D bSSFP T2 mapping, 3D qBOOST‐T2 
and coronary magnetic resonance angiography (CMRA) 
TABLE S3 Measured septal myocardial T2 values obtained 
with qBOOST‐T2 and conventional 2D bSSFP for 4 patients. 
A general T2 overestimation and lower precision is observed 
with the proposed technique
VIDEO S1 Bright‐blood 3D volume acquired with qBOOST‐
T2 for a representative healthy subject
VIDEO S2 Co‐registered black‐blood 3D volume acquired 
with qBOOST‐T2 for same healthy subject shown in Video S1
VIDEO S3 Co‐registered 3D T2 map acquired with 
qBOOST‐T2 for same healthy subject shown in Videos S1 
and S2. Uniform T2 quantification is observed across the 
whole myocardium
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